Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Borrega

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
European Urology Oncology|October 14, 2023
Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM StudyNuria Romero-Laorden, David Lorente, Guillermo de Velasco, et al.
Multiple Sclerosis and Related Disorders|August 27, 2022
Delayed cognitive processing and treatment status quo bias in early-stage multiple sclerosisGustavo Saposnik, Sanketh Andhavarapu, Susana Sainz de la Maza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2019
PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate CancerElena Castro, Nuria Romero-Laorden, Angela Del Pozo, et al.
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias|June 23, 2023
Prehospital care process and hospital outcomes in stroke-code cases: comparison of basic and advance life support ambulance attendanceSilvia Solà Muñoz, María Del Mar Escudero Campillo, Cristina Soro Borrega, et al.
European Journal of Neurology|June 21, 2021
Risk and outcomes of COVID-19 in patients with multiple sclerosisIrene Moreno-Torres, Virginia Meca Lallana, Lucienne Costa-Frossard, et al.
Clinical Drug Investigation|October 28, 2024
Real-World Experience with Diroximel Fumarate in Patients with Multiple Sclerosis: A Prospective Multicenter StudyClara Aguirre, Ana Alonso-Torres, Eduardo Agüera, et al.
Neurology|August 27, 2024
Investigating the 2023 MOGAD Criteria in Children and Adults With MOG-Antibody Positivity Within and Outside AttacksElianet Fonseca, Gemma Olivé-Cirera, Eugenia Martinez-Hernandez, et al.
Viruses|November 27, 2021
Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra LeoneansRodrigo Borrega, Diana K S Nelson, Anatoliy P Koval, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 15, 2015
Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish Oncologic Genitourinary Group (SOGUG) SPAZO studyB Pérez-Valderrama, J A Arranz Arija, A Rodríguez Sánchez, et al.
Frontiers in Immunology|November 28, 2024
Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosisFernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Noelia Villarrubia, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
European Urology Oncology|October 14, 2023
Prospective Assessment of Bone Metabolism Biomarkers and Survival in Metastatic Castration-resistant Prostate Cancer Patients Treated with Radium-223: The PRORADIUM StudyNuria Romero-Laorden, David Lorente, Guillermo de Velasco, et al.
Multiple Sclerosis and Related Disorders|August 27, 2022
Delayed cognitive processing and treatment status quo bias in early-stage multiple sclerosisGustavo Saposnik, Sanketh Andhavarapu, Susana Sainz de la Maza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 10, 2019
PROREPAIR-B: A Prospective Cohort Study of the Impact of Germline DNA Repair Mutations on the Outcomes of Patients With Metastatic Castration-Resistant Prostate CancerElena Castro, Nuria Romero-Laorden, Angela Del Pozo, et al.
Emergencias : Revista De La Sociedad Espanola De Medicina De Emergencias|June 23, 2023
Prehospital care process and hospital outcomes in stroke-code cases: comparison of basic and advance life support ambulance attendanceSilvia Solà Muñoz, María Del Mar Escudero Campillo, Cristina Soro Borrega, et al.
European Journal of Neurology|June 21, 2021
Risk and outcomes of COVID-19 in patients with multiple sclerosisIrene Moreno-Torres, Virginia Meca Lallana, Lucienne Costa-Frossard, et al.
Clinical Drug Investigation|October 28, 2024
Real-World Experience with Diroximel Fumarate in Patients with Multiple Sclerosis: A Prospective Multicenter StudyClara Aguirre, Ana Alonso-Torres, Eduardo Agüera, et al.
Neurology|August 27, 2024
Investigating the 2023 MOGAD Criteria in Children and Adults With MOG-Antibody Positivity Within and Outside AttacksElianet Fonseca, Gemma Olivé-Cirera, Eugenia Martinez-Hernandez, et al.
Viruses|November 27, 2021
Cross-Reactive Antibodies to SARS-CoV-2 and MERS-CoV in Pre-COVID-19 Blood Samples from Sierra LeoneansRodrigo Borrega, Diana K S Nelson, Anatoliy P Koval, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 15, 2015
Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish Oncologic Genitourinary Group (SOGUG) SPAZO studyB Pérez-Valderrama, J A Arranz Arija, A Rodríguez Sánchez, et al.
Frontiers in Immunology|November 28, 2024
Biomarkers of response to ocrelizumab in relapsing-remitting multiple sclerosisFernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Noelia Villarrubia, et al.
Pageof 15